Does CEFTRIAXONE Cause Malignant neoplasm progression? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Malignant neoplasm progression have been filed in association with CEFTRIAXONE (Ceftriaxone). This represents 0.1% of all adverse event reports for CEFTRIAXONE.
16
Reports of Malignant neoplasm progression with CEFTRIAXONE
0.1%
of all CEFTRIAXONE reports
11
Deaths
10
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CEFTRIAXONE?
Of the 16 reports, 11 (68.8%) resulted in death, 10 (62.5%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFTRIAXONE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CEFTRIAXONE Cause?
Off label use (2,201)
Drug ineffective (1,862)
Condition aggravated (950)
Dyspnoea (944)
Pyrexia (843)
Drug reaction with eosinophilia and systemic symptoms (793)
Rash (784)
Drug hypersensitivity (760)
Acute kidney injury (720)
Vomiting (668)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CEFTRIAXONE Alternatives Have Lower Malignant neoplasm progression Risk?
CEFTRIAXONE vs CEFTRIAXONE\CEFTRIAXONE
CEFTRIAXONE vs CEFUROXIME
CEFTRIAXONE vs CEFUROXIME AXETIL
CEFTRIAXONE vs CELEBREX
CEFTRIAXONE vs CELECOXIB